NO20032738L - Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av perindopril - Google Patents

Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av perindopril

Info

Publication number
NO20032738L
NO20032738L NO20032738A NO20032738A NO20032738L NO 20032738 L NO20032738 L NO 20032738L NO 20032738 A NO20032738 A NO 20032738A NO 20032738 A NO20032738 A NO 20032738A NO 20032738 L NO20032738 L NO 20032738L
Authority
NO
Norway
Prior art keywords
perindopril
pharmaceutical composition
controlled release
thermoformable
solid
Prior art date
Application number
NO20032738A
Other languages
English (en)
Other versions
NO20032738D0 (no
NO333590B1 (no
Inventor
Patrick Wuethrich
Herve Rolland
Gilles Briault
Gerald Pichon
Francois Tharrault
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20032738D0 publication Critical patent/NO20032738D0/no
Publication of NO20032738L publication Critical patent/NO20032738L/no
Publication of NO333590B1 publication Critical patent/NO333590B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
NO20032738A 2000-12-26 2003-06-16 Fast termoformbar farmasoytisk sammensetning for den kontrollerte frigivelse av perindopril NO333590B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0017013A FR2818550B1 (fr) 2000-12-26 2000-12-26 Composition pharmaceutique solide thermoformable pour la liberation controle de perindopril
PCT/FR2001/004133 WO2002051407A1 (fr) 2000-12-26 2001-12-21 Composition pharmaceutique solide thermoformable pour la liberation controlee de perindopril

Publications (3)

Publication Number Publication Date
NO20032738D0 NO20032738D0 (no) 2003-06-16
NO20032738L true NO20032738L (no) 2003-06-16
NO333590B1 NO333590B1 (no) 2013-07-15

Family

ID=8858188

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032738A NO333590B1 (no) 2000-12-26 2003-06-16 Fast termoformbar farmasoytisk sammensetning for den kontrollerte frigivelse av perindopril

Country Status (25)

Country Link
US (1) US20040115227A1 (no)
EP (1) EP1345605B1 (no)
JP (1) JP2004518666A (no)
KR (1) KR100542473B1 (no)
CN (1) CN1218696C (no)
AR (1) AR031972A1 (no)
AT (1) ATE299704T1 (no)
AU (1) AU2002228118B2 (no)
BR (1) BR0116536A (no)
CA (1) CA2432896A1 (no)
CZ (1) CZ297796B6 (no)
DE (1) DE60112117T2 (no)
DK (1) DK1345605T3 (no)
EA (1) EA005139B1 (no)
ES (1) ES2244672T3 (no)
FR (1) FR2818550B1 (no)
HU (1) HU230249B1 (no)
MX (1) MXPA03005792A (no)
NO (1) NO333590B1 (no)
NZ (1) NZ526405A (no)
PL (1) PL203836B1 (no)
PT (1) PT1345605E (no)
SK (1) SK286920B6 (no)
WO (1) WO2002051407A1 (no)
ZA (1) ZA200304405B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK50252005A3 (sk) * 2005-03-22 2006-10-05 Vúlm, A.S. Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
EA201490500A1 (ru) * 2011-08-30 2014-06-30 Университейт Гент Многослойный высвобождающий состав
RU2670447C2 (ru) * 2016-11-17 2018-10-23 Общество с ограниченной ответственностью "Изварино Фарма" Пероральная твердая лекарственная форма с микофенольной кислотой или ее солью для использования в качестве иммунодепрессанта для лечения или предупреждения отторжения трансплантата органа или ткани и способ ее получения

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002776A (en) * 1983-12-22 1991-03-26 Elan Corporation, Plc Controlled absorption diltiazem formulations
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
US5589499A (en) * 1992-11-25 1996-12-31 Weth; Gosbert Dopaminergic agents for the treatment of cerebral and peripheral blood flow disorders
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19724696A1 (de) * 1997-06-12 1998-12-24 Hexal Ag Pharmazeutische Zubereitung mit drei Pelletarten
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee

Also Published As

Publication number Publication date
HUP0302524A2 (hu) 2003-12-29
CZ297796B6 (cs) 2007-03-28
ATE299704T1 (de) 2005-08-15
EA200300664A1 (ru) 2003-12-25
HU230249B1 (hu) 2015-11-30
EP1345605B1 (fr) 2005-07-20
DE60112117T2 (de) 2006-06-01
AR031972A1 (es) 2003-10-08
EA005139B1 (ru) 2004-12-30
MXPA03005792A (es) 2003-09-10
CN1218696C (zh) 2005-09-14
DK1345605T3 (da) 2005-10-10
HK1063739A1 (en) 2005-01-14
HUP0302524A3 (en) 2007-09-28
ES2244672T3 (es) 2005-12-16
PT1345605E (pt) 2005-11-30
NO20032738D0 (no) 2003-06-16
WO2002051407A1 (fr) 2002-07-04
NO333590B1 (no) 2013-07-15
PL361663A1 (en) 2004-10-04
ZA200304405B (en) 2004-06-25
SK9432003A3 (en) 2003-12-02
JP2004518666A (ja) 2004-06-24
KR100542473B1 (ko) 2006-01-11
CA2432896A1 (fr) 2002-07-04
EP1345605A1 (fr) 2003-09-24
FR2818550A1 (fr) 2002-06-28
CZ20032008A3 (cs) 2004-01-14
FR2818550B1 (fr) 2003-02-07
US20040115227A1 (en) 2004-06-17
DE60112117D1 (de) 2005-08-25
NZ526405A (en) 2004-12-24
PL203836B1 (pl) 2009-11-30
CN1482909A (zh) 2004-03-17
BR0116536A (pt) 2003-10-21
SK286920B6 (sk) 2009-07-06
AU2002228118B2 (en) 2006-04-27
KR20030064877A (ko) 2003-08-02

Similar Documents

Publication Publication Date Title
NO20031692L (no) Fremgangsmåte for fremstilling av pulverformuleringer
FR2795324B1 (fr) Compositions pharmaceutiques stabilisees
AR026045A1 (es) Formulaciones de liberacion prolongada de derivados de eritromocina
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
CY2007031I2 (el) Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
NO20021540L (no) Sammensetninger med kontrollert frigivelse omfattende nimesulfid
IS2004B (is) Lyfjasamsetningar sem innihalda vorikónasól
EE05020B1 (et) Glburiidi ravimkoostis
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
HUP0101434A3 (en) Sulfonamide-containing indole compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
AR027907A1 (es) Composicion de liberacion controlada
EP1189597A4 (en) COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
NO20022589D0 (no) Antipicornavirus-forbindelser og blandinger, deres farmasöytiske anvendelse og materialer for syntese av dem
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
HUP0302522A3 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
AU2002228119A1 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
IS6021A (is) Lyfjasamsetningar sem innihalda sítalópram
NO20014301L (no) Sammensetninger med kontrollert frigivelse av betahistin
AU2001221695A1 (en) Solid pharmaceutical compositions for controlled release of active substances
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20032738D0 (no) Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av perindopril
AU2002228118A1 (en) Thermoformable solid pharmaceutical composition for controlled release of perindopril
NO20032297L (no) Fremgangsmåte for fremstilling av distamycinderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees